This market research report, Drug Discovery Technologies, provides an overview of the current state of the drug discovery market, existing platforms and products on the market, and detailed analysis of the competitive environments including new, potential venues for novel technologies and approaches. The study includes information about significant players in this field of study, trends and obstacles, and other information affecting development of new products, devices, and therapies in the drug discovery sector.

REASONS FOR DOING THIS STUDY

Drug discovery is one of the main sectors in the pharmaceutical industry. Drug development in general is a billion dollar industry and is highly dependent on its research and scientific advancement. Today, the process of drug discovery has become more systematic in comparison to the more physiological approaches in previous decades. In the current drug discovery market, the drug target is identified first, followed by a search for compounds or molecular entities that can inhibit or enhance its activity. Consequently, technology has a crucial impact on identification and validation of new drug candidates.

In general, the scientific and biotechnology community has seen many breakthrough technologies in the last decade. Surprisingly, there is a big gap between the initial introduction of new platforms and their further application and commercial success. Many analysts and industry insiders are trying to understand the reasons why, in spite of technological advancement, the pharmaceutical industry does not provide more successful drugs and why certain technologies fail to advance or accelerate the drug discovery process.

It is important to note that biological and pathological conditions are very complex. Therefore, in order to understand properly the effect of a technology or platform in drug discovery application, the market should be divided into main categories such as, for example, genomics or proteomics-based approaches and their related drug discovery technologies. Each sector has its novel trends and challenges that affect the drug discovery market in general and specific segments in particular.

Market participants vary among the different niches in the drug discovery industry. There is also a clear division between technology developers, manufacturer/ suppliers, and biotech companies. Each type of market participant has a different business strategy and is affected differently by positive or negative drivers discussed in this report.

In summary, this report will highlight the main aspects, sectors, and trends in the drug discovery technologies market, the major market participants, and the current and future trends in each sector. Drivers and challenges in each segment of the industry will be discussed in detail including forecasts for the next five years.

SCOPE AND FORMAT

This report represents a current and important business tool to evaluate new commercial opportunities in the drug discovery technology market. The geographic scope of this study covers the U.S., Europe, and companies worldwide. This market is complex and consists of a number of sectors, each affected differently by scientific and technological development. The report identifies main positive and negative factors in each sector and forecasts further trends, products, and technologies in every category of the industry.

METHODOLOGY AND INFORMATION SOURCES

Both primary and secondary research methodologies were used in preparing this report. The research methodology was more qualitative than quantitative in nature and employed a triangulating approach, which aids validity. Initially, a comprehensive and exhaustive search of the literature on drug discovery and already-marketed products was conducted. These secondary sources included drug discovery and science-related journals, textbooks, press releases, marketing literature, other product/promotional literature, annual reports, security analyst reports, and other publications. A patent search and analysis was also conducted.

In a second phase, a series of semi-structured interviews was conducted with company representatives, bench scientists, marketing representatives, and other personnel at biotech and pharmaceutical companies. Other resources included academic institutions and technology and consulting companies. These were a rich source of data. Subsequent analysis of the documents and interview notes was iterative.

INTENDED AUDIENCE

This report is intended for business development professionals, entrepreneurs and other investment groups in order to fully understand and properly evaluate each segment in the drug discovery technology market. It provides a company’s corporate development department with new insight into competitors’ positions and reveals new opportunities otherwise overlooked or less known to the public.

ANALYST CREDENTIALS

Dr. Marianna Tcherpakov has more than eight years of experience as a bench scientist specializing in the area of biochemistry, cell biology, and industrial assay development. She has contributed to a number of scientific publications and holds several patents. She has expertise as an assay development scientist and is familiar with different research field trends and likely future developments.

REPORT HIGHLIGHTS The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019. ...